济南大象药物研究有限公司

济南大象药物研究有限公司

山东省济南市市中区中海广场1602室

2008

50至59

不愿意公开

济南大象药物化学座落在山东省，主要从事医药原料药、中间体及精细化工品的研发和生产。 　　我们的目标是：不仅提供客户的医药化工产品，同时也为我们的客户创造价值。 　　我们有比较强的研发能力，能为客户提供各种特殊产品；可以提供从克级到公斤以及成吨的产品；能从事零下100度到400度反应。 　　将研发成果根据要求在规定的时间内迅速转化为工业生产是我们的特长。 　　诚信、共赢是我们的基本战略原则。 www.eosmedchem.com  info@eosmedchem.com Acalabrutinib(ACP-196) 注册1420477-60-6 Oncology Leukemia Ibrutinib 注册936563-96-1 Oncology Leukemia Ruxolitinib 注册941678-49-5 Oncology Leukemia Venetoclax (ABT-199) 注册1257044-40-8 Oncology Leukemia SNS-032(BMS-387032) 345627-80-7 Oncology Leukemia Pelitinib(EKB-569) 257933-82-7 Oncology Lung Cancer Rociletinib 注册1374640-70-6 Oncology Lung Cancer Alectinib 1256580-46-7 Oncology Lung Cancer Ceritinib 1032900-25-6 Oncology Lung Cancer www.eosmedchem.com  info@eosmedchem.com Vargatef(BIBF-1120) 928326-83-4 Oncology Lung Cancer Mereletinib(AZD-9291) 注册1421373-66-1 Oncology Lung Cancer Vemurafenib 918504-65-1 Oncology Melanoma Rucaparib(CO-1686) 注册283173-50-2 Oncology Ovarian Cancer Veliparib (ABT-888) 912444-00-9 Oncology Ovarian Cancer Niraparib 注册1038915-60-4 Oncology Ovarian Cancer Olaparib(AZD2281) 763113-22-0 Oncology Ovarian Cancer Abemaciclib (LY2835219) 注册1231929-97-7 Oncology Breast Cancer Ribociclib(LEE011) 1256963-02-6 Oncology Breast Cancer Palbociclib 注册827022-32-2 Oncology Breast Cancer Pazopanib 635702-64-6 Oncology Kidney Cancer Lenvatinib(E7080) 417716-92-8 Oncology Kidney Cancer Brigatinib(AP26113) 1197958-12-5 Oncology Gastric Cancer Osimertinib(AZD-9291) 1421373-65-0 Oncology Gastric Cancer Idelalisib(CAL-101) 1146702-54-6 Oncology Blood Cancer Apalutamide (ARN-509) 956104-40-8 Prostate Cancer Dapagliflozin 461432-26-8 Diabetes 2 Empagliflozin 注册864070-44-0 Diabetes 2 Ertugliflozin(PF-04971729) 1210344-57-2 Diabetes 2 Canagliflozin 842133-18-0 Diabetes 2 Dulaglutide 注册923950-07-7 Diabetes 2 Liraglutide 204656-20-2 Diabetes 2 Albiglutide 782500-75-8 Diabetes 2 Velpatasvir 1377049-84-7 Hepatitis C Glecaprevir 1365970-03-1 Hepatitis C Pibrentasvir 注册1353900-92-1 Hepatitis C www.eosmedchem.com  info@eosmedchem.com Cobicistat (GS-9350) 1004316-88-4 HIV Tofacitinib 注册540737-29-9 Rheumatism Upadacitinib 1310726-60-3 Rheumatism Baricitinib 注册1187594-09-7 Rheumatism Filgotinib (GLPG0634) 1206161-97-8 Rheumatism Obeticholic 注册459789-99-2 Cirrhosis Of The Liver Vorapaxar(SCH 530348) 705260-08-8 Anticoagulant Edoxaban 480449-70-5 Antithrombotic Ivacaftor(VX770) 873054-44-5 Cystic Fibrosis Lumacaftor 注册936727-05-8 Cystic Fibrosis Suvorexant(MK-4305) 1030377-33-3 Insomnia Apremilast 608141-41-9 Psoriasis Selexipag 475086-01-2 Rare Disease Pulmonary Hypertension Masitinib (AB1010) 790299-79-5 Rare Disease Amyotrophic Lateral Elagolix 注册832720-36-2 Rare Disease Endometriosis Olodaterol 868049-49-4 Chronic obstructive pulmonary disease Macitentan 注册441798-33-0 Pulmonary hypertension Anacetrapib 875446-37-0 Coronary artery disease Cinacalcet 364782-34-3 Anti hyperparathyroidism Rolapitant 注册914462-92-3 Cancer patients radiotherapy Ozanimod 1306760-87-1 Newcastle Multiple Sclerosis www.eosmedchem.com  info@eosmedchem.com    

合同定制

250001

www.eosmedchem.com info@eosmedchem.com Acalabrutinib(ACP-196) 注册1420477-60-6 Oncology Leukemia Ibrutinib 注册936563-96-1 Oncology Leukemia Ruxolitinib 注册941678-49-5 Oncology Leukemia Venetoclax (ABT-199) 注册1257044-40-8 Oncology Leukemia SNS-032(BMS-387032) 345627-80-7 Oncology Leukemia Pelitinib(EKB-569) 257933-82-7 Oncology Lung Cancer Rociletinib 注册1374640-70-6 Oncology Lung Cancer Alectinib 1256580-46-7 Oncology Lung Cancer Ceritinib 1032900-25-6 Oncology Lung Cancer www.eosmedchem.com info@eosmedchem.com Vargatef(BIBF-1120) 928326-83-4 Oncology Lung Cancer Mereletinib(AZD-9291) 注册1421373-66-1 Oncology Lung Cancer Vemurafenib 918504-65-1 Oncology Melanoma Rucaparib(CO-1686) 注册283173-50-2 Oncology Ovarian Cancer Veliparib (ABT-888) 912444-00-9 Oncology Ovarian Cancer Niraparib 注册1038915-60-4 Oncology Ovarian Cancer Olaparib(AZD2281) 763113-22-0 Oncology Ovarian Cancer Abemaciclib (LY2835219) 注册1231929-97-7 Oncology Breast Cancer Ribociclib(LEE011) 1256963-02-6 Oncology Breast Cancer Palbociclib 注册827022-32-2 Oncology Breast Cancer Pazopanib 635702-64-6 Oncology Kidney Cancer Lenvatinib(E7080) 417716-92-8 Oncology Kidney Cancer Brigatinib(AP26113) 1197958-12-5 Oncology Gastric Cancer Osimertinib(AZD-9291) 1421373-65-0 Oncology Gastric Cancer Idelalisib(CAL-101) 1146702-54-6 Oncology Blood Cancer Apalutamide (ARN-509) 956104-40-8 Prostate Cancer Dapagliflozin 461432-26-8 Diabetes 2 Empagliflozin 注册864070-44-0 Diabetes 2 Ertugliflozin(PF-04971729) 1210344-57-2 Diabetes 2 Canagliflozin 842133-18-0 Diabetes 2 Dulaglutide 注册923950-07-7 Diabetes 2 Liraglutide 204656-20-2 Diabetes 2 Albiglutide 782500-75-8 Diabetes 2 Velpatasvir 1377049-84-7 Hepatitis C Glecaprevir 1365970-03-1 Hepatitis C Pibrentasvir 注册1353900-92-1 Hepatitis C www.eosmedchem.com info@eosmedchem.com Cobicistat (GS-9350) 1004316-88-4 HIV Tofacitinib 注册540737-29-9 Rheumatism Upadacitinib 1310726-60-3 Rheumatism Baricitinib 注册1187594-09-7 Rheumatism Filgotinib (GLPG0634) 1206161-97-8 Rheumatism Obeticholic 注册459789-99-2 Cirrhosis Of The Liver Vorapaxar(SCH 530348) 705260-08-8 Anticoagulant Edoxaban 480449-70-5 Antithrombotic Ivacaftor(VX770) 873054-44-5 Cystic Fibrosis Lumacaftor 注册936727-05-8 Cystic Fibrosis Suvorexant(MK-4305) 1030377-33-3 Insomnia Apremilast 608141-41-9 Psoriasis Selexipag 475086-01-2 Rare Disease Pulmonary Hypertension Masitinib (AB1010) 790299-79-5 Rare Disease Amyotrophic Lateral Elagolix 注册832720-36-2 Rare Disease Endometriosis Olodaterol 868049-49-4 Chronic obstructive pulmonary disease Macitentan 注册441798-33-0 Pulmonary hypertension Anacetrapib 875446-37-0 Coronary artery disease Cinacalcet 364782-34-3 Anti hyperparathyroidism Rolapitant 注册914462-92-3 Cancer patients radiotherapy Ozanimod 1306760-87-1 Newcastle Multiple Sclerosis www.eosmedchem.com info@eosmedchem.com

www.eosmedchem.com  info@eosmedchem.com Acalabrutinib(ACP-196) 注册1420477-60-6 Oncology Leukemia Ibrutinib 注册936563-96-1 Oncology Leukemia Ruxolitinib 注册941678-49-5 Oncology Leukemia Venetoclax (ABT-199) 注册1257044-40-8 Oncology Leukemia SNS-032(BMS-387032) 345627-80-7 Oncology Leukemia Pelitinib(EKB-569) 257933-82-7 Oncology Lung Cancer Rociletinib 注册1374640-70-6 Oncology Lung Cancer Alectinib 1256580-46-7 Oncology Lung Cancer Ceritinib 1032900-25-6 Oncology Lung Cancer www.eosmedchem.com  info@eosmedchem.com Vargatef(BIBF-1120) 928326-83-4 Oncology Lung Cancer Mereletinib(AZD-9291) 注册1421373-66-1 Oncology Lung Cancer Vemurafenib 918504-65-1 Oncology Melanoma Rucaparib(CO-1686) 注册283173-50-2 Oncology Ovarian Cancer Veliparib (ABT-888) 912444-00-9 Oncology Ovarian Cancer Niraparib 注册1038915-60-4 Oncology Ovarian Cancer Olaparib(AZD2281) 763113-22-0 Oncology Ovarian Cancer Abemaciclib (LY2835219) 注册1231929-97-7 Oncology Breast Cancer Ribociclib(LEE011) 1256963-02-6 Oncology Breast Cancer Palbociclib 注册827022-32-2 Oncology Breast Cancer Pazopanib 635702-64-6 Oncology Kidney Cancer Lenvatinib(E7080) 417716-92-8 Oncology Kidney Cancer Brigatinib(AP26113) 1197958-12-5 Oncology Gastric Cancer Osimertinib(AZD-9291) 1421373-65-0 Oncology Gastric Cancer Idelalisib(CAL-101) 1146702-54-6 Oncology Blood Cancer Apalutamide (ARN-509) 956104-40-8 Prostate Cancer Dapagliflozin 461432-26-8 Diabetes 2 Empagliflozin 注册864070-44-0 Diabetes 2 Ertugliflozin(PF-04971729) 1210344-57-2 Diabetes 2 Canagliflozin 842133-18-0 Diabetes 2 Dulaglutide 注册923950-07-7 Diabetes 2 Liraglutide 204656-20-2 Diabetes 2 Albiglutide 782500-75-8 Diabetes 2 Velpatasvir 1377049-84-7 Hepatitis C Glecaprevir 1365970-03-1 Hepatitis C Pibrentasvir 注册1353900-92-1 Hepatitis C www.eosmedchem.com  info@eosmedchem.com Cobicistat (GS-9350) 1004316-88-4 HIV Tofacitinib 注册540737-29-9 Rheumatism Upadacitinib 1310726-60-3 Rheumatism Baricitinib 注册1187594-09-7 Rheumatism Filgotinib (GLPG0634) 1206161-97-8 Rheumatism Obeticholic 注册459789-99-2 Cirrhosis Of The Liver Vorapaxar(SCH 530348) 705260-08-8 Anticoagulant Edoxaban 480449-70-5 Antithrombotic Ivacaftor(VX770) 873054-44-5 Cystic Fibrosis Lumacaftor 注册936727-05-8 Cystic Fibrosis Suvorexant(MK-4305) 1030377-33-3 Insomnia Apremilast 608141-41-9 Psoriasis Selexipag 475086-01-2 Rare Disease Pulmonary Hypertension Masitinib (AB1010) 790299-79-5 Rare Disease Amyotrophic Lateral Elagolix 注册832720-36-2 Rare Disease Endometriosis Olodaterol 868049-49-4 Chronic obstructive pulmonary disease Macitentan 注册441798-33-0 Pulmonary hypertension Anacetrapib 875446-37-0 Coronary artery disease Cinacalcet 364782-34-3 Anti hyperparathyroidism Rolapitant 注册914462-92-3 Cancer patients radiotherapy Ozanimod 1306760-87-1 Newcastle Multiple Sclerosis www.eosmedchem.com  info@eosmedchem.com  

制造商

北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

CNM-Au8 (gold nanocrystal)(NA);VIA-3196-009(NA);VX-008(130-95-0);VIA-3196-007(141-30-0);Allylacetone(109-49-9);3-CHLORO-4-METHYLPHENOL(615-62-3);Sodium 4-phenylbutyrate(1716-12-7);VIA-3196-001(5930-28-9);PF-06651600-001(3430-14-6);NIROG-003(5813-64-9);2,3-Dicyanohydroquinone(4733-50-0);ALDEHYDE DEHYDROGENASE(9028-88-0);Ethylhydrocupreine HCl,Optochin HCl(3413-58-9);8-Aminooctanoic acid(1002-57-9);Ganaxolone(38398-32-2);Vamorolone(13209-41-1);Tapinarof (DMVT-505)(79338-84-4);Ursodoxicoltaurine+combo (AMX-0035)(14605-22-2);Resiniferatoxin(57444-62-9);delta6-Cannabidiol(95588-88-8);Gepirone(83928-76-1);1,3-DIHYDROXYACETONE DIMER(26776-70-5);2-Iodo-6-chloropurine(18552-90-4);4-AMINO-1-PIPERIDINE-ETHANOL(89850-72-6);3,3-Diphenyltetrahydrofuran-2-ylidene(dimethyl)ammonium bromide(37743-18-3);(Z)-2-Pentenoic acid(16666-42-5);Ethyl 4,5,6,7-Tetrahydroisoindole-1-carboxylate(65880-17-3);3-tert-Butyl-9H-carbazole(22401-74-7);Sparsentan(254740-64-2);Lucerastat(141206-42-0);Roxadustat(808118-40-3);Roluperidone(359625-79-9);Tucatinib(937263-43-9);Selumetinib(606143-52-6);Blarcamesine hydrochloride(195615-84-0);Belumosudil(911417-87-3);Omecamtiv mecarbil(873697-71-3);Daprodustat(960539-70-2);Melphalan flufenamide(380449-51-4);Lumateperone(313368-91-1);Encequidar(849675-66-7);Lurbinectedin(497871-47-3);Samidorphan(852626-89-2);Islatravir(865363-93-5);Ponesimod(854107-55-4);Pevonedistat(905579-51-3);Blarcamesine(195615-83-9);Infigratinib(872511-34-7);Lonafarnib(193275-84-2);Voclosporin(515814-01-4);Plinabulin(714272-27-2);Reproxalap(916056-79-6);Palovarotene(410528-02-8);Givinostat(497833-27-9);Maralixibat chloride (Lopixibat chloride)(228113-66-4);Maribavir(176161-24-3);Elacestrant(722533-56-4);Trofinetide(853400-76-7);Quizartinib(950769-58-1);Bardoxolone methyl(218600-53-4);Ceftolozane (CXA-101) TFA salt(936111-69-2);Cenobamate(502487-67-4);elafibranor/GFT505(923978-27-2);Levoketoconazole(142128-57-2);Linzagolix (OBE-2109)(935283-04-8);Navitoclax )(923564-51-6);Testosterone Tridecanoate(488836-58-4);Tradipitant(622370-35-8);Vonoprazan(881681-00-1);Xanomeline(141064-23-5);Xanomeline (LY-246708)+combo(131986-45-3);Osilodrostat (LCI-699)(928134-65-0);Elinzanetant(929046-33-3);Crinecerfont(321839-75-2);Fezolinetant HCL(929016-98-8);Temanogrel(887936-68-7);Ecopipam HCL(190133-94-9);Posiphen(116839-68-0);Crinecerfont(752253-39-7);Seladelpar(851528-79-5);Cadisegliatin(859525-02-3);Clazosentan (Ro-61-1790, ACT-108475)(180384-56-9);Mavorixafor (AMD-070, X4P-001)(558447-26-0);Encaleret(787583-71-5);Perfluorohexyloctane(133331-77-8);Resmetirom (MGL-3196)(920509-32-6);LY-001(148893-10-1);VX-004(888318-22-7);VX-016(100137-47-1);RMC-011(138323-07-6);OMAV-001(218600-44-3);NIROG-001(865774-07-8);NIROG-002(865774-76-1);NIROG-004(865774-15-8);NIROG-006(865774-26-1);NIROG-007(865774-79-4);NIROG-008(843644-23-5);173937-91-2(173937-91-2);1-Cyclopentene-1-heptanoic acid, 5-oxo-3-[(triethylsilyl)oxy]-, Methyl ester(112713-92-5);4-(chloromethyl)-2-methylpyridine hydrochloride(847610-87-1);Silicate(4-?)?, [2,?5-?dioxo-?1-?pyrrolidinyl 6-?[[[3-?[(29H,?31H-?phthalocyanin-?1-?yl-?κN29,?κN30,?κN31,?κN32)?oxy]?propoxy]?carbonyl]?amino]?hexanoato(2-?)?]?bis[N-?[3-?[(hydroxy-?κO)?dimethylsilyl]?propyl]?-?3-?sulfo-?N,?N-?bis(3-?sulfopropyl)?-?1-?pr(916821-46-0);N-[[(5R)-3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide(872992-20-6);THIAZOLE ORANGE(107091-89-4);(S)-N1-(2-aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine.3HCl(221640-06-8);2-Bromo-1,3-difluoro-5-iodobenzene(155906-10-8);4-BROMO-6-FLUORO (1H)INDAZOLE(885520-35-4);(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol(101692-02-8);6-Chloro-4-hydroxy-[1,5]naphthyridine-3-carboxylic acid ethyl ester(127094-58-0);Odevixibat(501692-44-0);Elobixibat(439087-18-0);Desethyl Sildenafil(139755-91-2);2-nonyl-1-undecanol(124324-24-9);tert-butyl 5-forMyl-1H-iMidazol-2-ylcarbaMate(917919-51-8);Phosphonium, tetrabutyl-, salt with 4-methyl-.alpha.,.alpha.-bis(trifluoromethyl)benzenemethanol (1:1)(893414-71-6);(E)-8-methoxy-2-((naphthalen-1-yloxy)methyl)-8-oxooct-2-enoic acid(936221-69-1);Saroglitazar(495399-09-2);Tipifarnib(192185-72-1);Mitapivat(1260075-17-9);zanubrutinib(1691249-45-2);Mavacamten(1642288-47-8);Apabetalone(1044870-39-4);Pemigatinib(1513857-77-6);Umbralisib(1532533-67-7);Cedazuridine(1141397-80-9);Selpercatinib(2152628-33-4);Abrocitinib(1622902-68-4);Venglustat(1629063-78-0);Trilaciclib(1374743-00-6);Ripretinib(1442472-39-0);Hexadeuterodextromethorphan(1079043-55-2);Tepotinib(1100598-32-0);Vorasidenib(1644545-52-7);Ibrexafungerp(1207753-03-4);Setmelanotide(1294000-61-5);Lemborexant(1369764-02-2);Surufatinib(1308672-74-3);Berotralstat(1809010-50-1);Tenapanor(1234423-95-0);Etrasimod(1206123-37-6);Risdiplam(1825352-65-5);Sotorasib(2296729-00-3);Daridorexant(1505484-82-1);Seltorexant(1293281-49-8);Tirzepatide(2023788-19-2);BLU-667(Pralsetinib)(2097132-94-8);Belzutifan(1672668-24-4);Mobocertinib(1847461-43-1);Sitravatinib(1123837-84-2);Vibegron(1190389-15-1);Adagrasib(2326521-71-3);Aprocitentan(1103522-45-7);Fosgemcitabine palabenamide(1562406-27-2);Rilzabrutinib (PRN-1008)(1575596-29-0);Pelabresib(1380087-89-7);Finerenone (BAY-94-8862)(1050477-31-0);Difelikefalin(1024828-77-0);Ensifentrine (RPL-554)(1884461-72-6);Savolitinib(1313725-88-0);Pirtobrutinib(2101700-15-4);Aficamten(2364554-48-1);Ritlecitinib(1792180-81-4);Avacopan(1346623-17-3);Paltusotine(2172870-89-0);Fezolinetant(1629229-37-3);Iptacopan(1644670-37-0);Olutasidenib(1887014-12-1);Nirogacestat(1290543-63-3);Lenacapavir(2189684-44-2);Brensocatib (AZD-7986)(1802148-05-5);Omaveloxolone(1474034-05-3);Milvexian (BMS-986177)(1802425-99-5);Momelotinib(1056634-68-4);Repotrectinib(1802220-02-5);Acoramidis(1446711-81-4);Amcenestrant(2114339-57-8);Capivasertib(1143532-39-1);Cefiderocol(1225208-94-5);Deucravacitinib(1609392-27-9);Molnupiravir(2349386-89-4);Erdafitinib(1346242-81-6);Evobrutinib(1415823-73-2);Foscarbidopa/(1907685-81-7);Futibatinib (TAS-120)(1448169-71-8);Giredestrant (GDC-9545)(1953133-47-5);Parsaclisib(1426698-88-5);Poziotinib (HM-781-36)(1092364-38-9);Simufilam PTI-125(1224591-33-6);Tolebrutinib/ TAK-165(1971920-73-6);Trilaciclib(1977495-97-8);Ulotaront (SEP-363856)(1310426-33-5);Vadadustat(1000025-07-9);Vazegepant hydrochloride(1414976-20-7);Zandelisib(1401436-95-0);Zavegepant(1337918-83-8);Zilucoplan(1841136-73-9);Zuranolone(1632051-40-1);Uproleselan sodium (GMI-1271)(1914993-95-5);Surufatinib (HPML-012)(1816307-67-1);Deuruxolitinib(1513883-39-0);Bezuclastinib(1616385-51-3);Camlipixant(1621164-74-6);Fruquintinib(1194506-26-7);Rezafungin(1396640-59-7);Asciminib(1492952-76-7);Sotagliflozin(1018899-04-1);Sabizabulin(1332881-26-1);Fluzoparib(1358715-18-0);Anlotinib(1058156-90-3);Abiraterone ecanoate(2486052-18-8);GSK 2330672(1345982-69-5);Vanzacaftor(2374124-49-7);Unesbulin(1610964-64-1);Samuraciclib HCL(1805789-54-1);Brepocitinib(1883299-62-4);Alrizomadlin(1818393-16-6);REN-101(1604815-32-8);Abivertinib(1557267-42-1);Lotilaner (TP-05)(1369852-71-0);Orforglipron (LY-3502970)(2212020-52-3);Danicopan (ACH-4471)(1903768-17-1);Zanzalintinib (XL-092)(2367004-54-2);Tovorafenib (DAY-101)(1446113-23-0);Ritlecitinib (PF-06651600)(2140301-97-7);Fenebrutinib(1434048-34-6);Lazertinib(1903008-80-9);Crinecerfont(2649012-17-7);Durlobactam(1467829-71-5);Gefapixant (MK-7264)(1015787-98-0);Estrogen receptor antagonist 2(2222844-89-3);Tavapadon(1643489-24-0);Suzetrigine (VX-548)(2649467-58-1);KT-001(2434842-07-4);KT-002(2434853-23-1);KT-003(2434841-21-9);KT-004(2688840-94-8);VX-001(2875066-92-3);VX-002(2875066-98-9);VX-003(2875066-95-6);VX-005(2875067-01-7);VX-006(2875066-38-7);VX-007(2875067-17-5);VX-009(2875066-62-7);VX-010(2879218-02-5);VX-013(1558274-26-2);VX-014(2875066-35-4);VX-015(2649469-37-2);VIA-3196-008(1581304-46-2);PF-06651600-003(1150618-39-5);PF-06651600-004(2101218-65-7);PF-06651600-005(1207853-21-1);PF-06651600-006(1207947-49-6);PF-06651600-008(2042650-65-5);RLY-004(3025731-47-6);RLY-005(3025731-48-7);RLY-006(3025731-49-8);RLY-007(2549188-28-3);RLY-008(3025731-50-1);RLY-009(2772530-41-1);RMC-001(2641451-42-3);RMC-002(2641451-59-2);RMC-003(2641451-43-4);RMC-004(2641451-45-6);RMC-005(2641451-46-7);RMC-007(2641820-94-0);RMC-008(2641824-62-4);RMC-009(2865162-03-2);RMC-010(2865162-04-3);RMC-012(2865162-05-4);RMC-013(2865162-06-5);RMC-014(2865162-07-6);RMC-015(2865162-08-7);RMC-016(2865162-01-0);RMC-017(2641824-53-3);OMAV-002(1192122-92-1);OMAV-003(1192122-95-4);OMAV-004(1192123-13-9);NIROG-010(1309869-67-7);16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers)(1040085-99-1);1026355-73-6(1026355-73-6);Ibuprofen Impurity 67(1314907-71-5);GS-6207(2189684-44-2);AB 928(2239273-34-6);tert-butyl (E)-4-(3-(dimethylamino)acryloyl)piperidine-1-carboxylate(1799799-87-3);Methanone, [2-(1H-indol-3-yl)-1H-imidazol-5-yl](3,4,5-trimethoxyphenyl)-(1332881-26-1);AS-2444697(1287665-60-4);GSK2795039(1415925-18-6);SILDENAFIL N-OXIDE(1094598-75-0);Sildenafil EP IMpurity D(1357931-55-5);1,3,5-Triazine, 2-chloro-4,6-di(phenyl-2,3,4,5,6-d5)-(1300115-09-6);Cyclohexanecarboxylic acid, 4-(4-chloro-6-methyl-2-pyrimidinyl)-1-methoxy-, methyl ester(2097133-31-6);LCL161(1005342-46-0);Flurbiprofen IMpurity B(1797883-74-9);LoperaMide IMpurity A(1391052-94-0);(2-Methylpiperidin-3-Yl)Methanol(WX601246)(1314914-80-1);Bis-Mal-Lysine-PEG4-TFP ester(1426164-53-5);Aripiprazole Dimer(1797986-18-5);AT-527 base(1998705-64-8);AT-527(2241337-84-6);Rivoceranib (Apatinib)(1218779-75-9 (mesylate));IRDye 700DX NHS Ester(916821-46-0)

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E2E60

Intermediates & Fine Chemicals;CMO & CRO